These findings could be interesting not only for LGMDR1 patients, but for dysferlinopathy and titinopathy patients in whom a secondary reduction of CANP3 has been described [86, 87]. Here, CAPN3 is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.